Educational Sessions
Saturday, April 6, 2019
8:00 a.m. – Noon
Drugs and Supplements Affecting Patient Care Including
New FDA Drug Approvals, Herbals, Antioxidants and Nutraceuticals
Presented by Richard L. Wynn, PhD
About the Speaker
4 CE credits recommended for dentists, specialists, hygienists and dental assistants
This fast paced 4 hour (minus short break)
course will discuss the latest supplement issues
that may have an effect on pharmacotherapy in
patient treatment. Mainstream supplements
and the scientific support or lack thereof will be
described for herbal and anti-arthritic products.
Herbal products include echinacea, ginkgo,
St John’s wort, ginseng, red yeast rice and many
others. Alternative anti-arthritic products will
include SAM-e, chondroitin. glucosamine
sulfate and MSM. Antioxidants such as dark
chocolate, coffee, beet juice will be discussed
along with nutraceuticals including fish oil
supplements, krill oil, seafood, vitamin D,
calcium products, turmeric and more.
In addition, new reports linking the latest in
C-reactive protein (CRP) levels and the risk of
heart attacks will be presented along with
new studies on cardiovascular benefits (or lack
thereof ) of moderate alcohol consumption.
For conventional drugs, a listing of FDA class
of 2017 and 2018 new drug approvals will be
in the handout. There will be an attempt to
explain in simple terms these new and very
expensive target-specific drugs to treat rare
diseases (think of secukinumab (Cosentyx) to
treat psoriatic arthritis and known as IL-17A
inhibitor (huh?). The interesting new report
Richard L. Wynn, PhD
on aspirin cardioprotection based on patient
weight and the document from the American
Dental Association calling for antibiotic
stewardship also will be reviewed.
Finally, big Pharma is developing “anti-aging
drugs.” The supplement NIAGEN, available
over-the-counter, will be described relative to
the scientific support for this supplement in
anti-aging research as published in the journal
SCIENCE.
Upon completion of the course, the participant
should be able to:
List the latest new FDA drug approvals and
describe the ADA’s definition of antibiotic
stewardship.
List the important herbal supplements,
antioxidants and anti-arthritic supplements
and define those with scientific support and
those lacking support for effectiveness. List
those having possible dental peri- and
postoperative complications and describe
the complications.
Dr. Wynn is Professor of
Pharmacology at the University
of Maryland Dental School in
Baltimore. He is the lead author
and chief editor of Drug
Information Handbook for
Dentistry, now in its 24th
edition, published by
LexiComp, Inc. His chief interest
is teaching pharmacology to
dental and dental hygiene
students, and keeping dental
professionals informed of
current and new drug
information relative to dental
practice. Dr. Wynn has no
relevant financial relationships
to disclose.
List the most recent findings on
cardioprotective aspirin based on
patient weight.
Describe the mechanism of NIAGEN as
a candidate for an ant-aging drug.
PDA is an ADA CERP Recognized Provider
ADA CERP is a service of the American Dental Association to assist dental
professionals in identifying quality providers of continuing dental education.
ADA CERP does not approve or endorse individual courses or instructors, nor
does it imply acceptance of credit hours by boards of dentistry.
Concerns or complaints about a CE provider may be directed to the provider
or to ADA CERP at www.ada.org/cerp.
N OVEM BER/DECEM BER 2018 | P EN N SYLVAN IA DEN TAL JOURNAL
33